Medicare's New Weight-Loss Drug Program: GLP-One Bridge
Durham News Today | 2 Min News | The Daily News Now! · The Daily News Now!
Audio is streamed directly from the publisher (api.fastcast.ai) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Medicare introduces the GLP-one Bridge, a new program starting July 1st, allowing eligible beneficiaries to access weight-loss drugs like Wegovy and Zepbound for just $50 a month. This program covers injectable and pill versions of these drugs, with strict eligibility criteria based on body mass index and health conditions. The $50 copay does not count towards Part D deductibles or out-of-pocket caps, and low-income assistance programs do not apply. The program lasts until December 31, 2026, and will transition to a voluntary Part D option in 2027.
Support the show:
Get a discount at https://solipillow.com/discount/dnn.
Advertise on DNN:
[email protected]
This is an automated, high-level news summary based on public reporting.
Report issues to [email protected].
View sources & latest updates:
https://sources.thednn.ai/e8ec3a70d0995cc8